MedComm · Published 2026-07-01 · DOI 10.1002/mco2.70838
Yu‐Han Ai, Ting‐Ting Xu, Sen Lin, Meng‐Yu Xiao, Yun‐Xia Lin, Hao‐Wen Ma, Yue‐Yang Liu, Yao‐Jie Wang, Lu‐Ning Yin, Mei Huang, Yong‐Da Liu, Chao Zhu, Xiao‐Ting Zhu, Ji‐Hang Yuan
ABSTRACT CD8+ tissue‐resident memory T (TRM) cells play a pivotal role in local immune regulation. These noncirculating T cells are uniquely positioned to orchestrate rapid site‐specific immune responses, making them central to understanding tissue‐specific immunity. Prior work has demonstrated that CD8+ TRM cells possess dual functions: they are essential for immune defense against pathogens and malignancies, yet also drive pathological inflammation in autoimmune disorders. Furthermore, emerging evidence has begun to elucidate the intrinsic molecular mechanisms controlling this functional duality and to develop intervention strategies for its precise modulation. Here, we review current knowledge of the origin, transcriptional regulation, phenotypic characteristics, and functions of CD8+ TRM cells. We discuss how TRM cells correlate with clinical outcomes in diverse cancer types. Furthermore, we explore immune checkpoint inhibitors and other immunotherapies that target TRM cells and their therapeutic implications from preclinical and translational human research. This review provides a comprehensive understanding of the molecular and cellular mechanisms governing TRM cell activity and details their roles in health and disease. Ultimately, the framework of tissue immune networks reveals that leveraging TRM cell development, tissue residency, and metabolism processes enables the design of innovative treatments for these diseases.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Ai, Y., Xu, T., Lin, S., et al. (2026). CD8 + Tissue‐Resident Memory T Cells in Health and Disease. MedComm. https://doi.org/10.1002/mco2.70838